ClassID:

116834

C12Y304/21027 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Coagulation factor XIa (3.4.21.27)

Recent Application in this class:
#1
20260085320
2026-03-26

GALNAC MONOMER COMPRISING RIBOSE RING OR DERIVATIVE STRUCTURE THEREOF AND USE THEREOF IN LIVER-TARGETED DELIVERY OF SMALL NUCLEIC ACID DRUGS

#2
20250345404
2025-11-13

COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE

#3
20250250573
2025-08-07

POLYNUCLEIC ACID MOLECULES FOR INHIBITING EXPRESSION OF FXI, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#4
20250018062
2025-01-16

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

#5
20230338479
2023-10-26

HIGH-ACTIVITY BLOOD COAGULATION FACTOR XI MUTANT ALA570THR

#6
20230263822
2023-08-24

MODULATION OF FACTOR 11 EXPRESSION

#7
20230089502
2023-03-23

PRODUCTS AND COMPOSITIONS

#8
20220364087
2022-11-17

PRODUCTS AND COMPOSITIONS

#9
20220218639
2022-07-14

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

#10
20210207115
2021-07-08

Methods for preparing and using highly active blood coagulation factor XI mutant and gene therapy/editing vector and recombinant/fusion protein thereof

#11
20210169921
2021-06-10

Modulation of factor 11 expression

#12
20200338123
2020-10-29

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

#13
20200261386
2020-08-20

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

#14
20200155706
2020-05-21

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#15
20200000839
2020-01-02

Modulation of Factor 11 expression

#16
20190314527
2019-10-17

In vivo production of proteins

#17
20180340163
2018-11-29

RECOMBINANT SERINE PROTEASES

#18
20180311381
2018-11-01

Modified Polynucleotides for the production of biologics and proteins associated with human disease

#19
20170368200
2017-12-28

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#20
20170348436
2017-12-07

In vivo production of proteins

#21
20170321218
2017-11-09

Factor XIa-specific aptamers

#22
20170189362
2017-07-06

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

#23
20160206732
2016-07-21

EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF

#24
20160075733
2016-03-17

Modified polynucleotides for the production of biologics and proteins associated with human disease

#25
20160024488
2016-01-28

METHOD FOR PREPARING A CONCENTRATE OF FACTOR XI

#26
20140046028
2014-02-13

Method for preparing a concentrate of factor XI

#27
20120083522
2012-04-05

MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI

#28
20100234291
2010-09-16

Preparation of low bleeding anticoagulant fusion protein and its use

#29
20100137414
2010-06-03

Modulation of factor 11 expression

#30
20100113345
2010-05-06

Preparation of low bleeding anticoagulant fusion protein and its use

#31
20100062512
2010-03-11

PURIFICATION OF FACTOR XI

#32
20050181978
2005-08-18

Therapeutic use of factor XI